Anti-Ro and anti-La seem to be less frequent in pSS patients with neurological involvement (40%) compared to patients without neurological manifestations (60% of positivity), so, it is necessary for more markers are necessary in pSS to better classify subpopulations of patients with neurological involvement [39]. The gene discussed is SSB; the disease is peeling skin syndrome.